Remora Biotech

Remora Biotech is at the forefront of immunotherapy ventures, making significant contributions to the ever-evolving landscape of medicine and society. With a focus on developing innovative life-changing immunotherapies, Remora Biotech leverages entrepreneurial experience and strategic investments to nurture and scale its capabilities.

Based in Lausanne at Rue du Petit-Chêne 12, 1003, CH, Remora Biotech creates, finances, and manages a portfolio of daughter companies, guiding them from the initial discovery phase through to clinical proof-of-concept. The company's mission is to maximize the success and strategic value of these ventures for pharma partners, while maintaining capital efficiency. Remora Biotech's growing team and extensive network of academic partners, business-oriented scientists, patent experts, drug developers, and finance professionals drive this mission forward.

Remora Biotech is dedicated to advancing the field of immunotherapy and invites investors to join them in this high-growth, high-impact sector. This is an invitation to become a shareholder in Remora Biotech and co-invest in their promising daughter companies. We invite the management team at Remora Biotech to create a customized and exclusive company showcase and product listing on our platform, enhancing their visibility and commercial reach.